Position in INCY
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$21,223,306
-$597,159 QoQ
Shares Held
225,492
+2.1% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,683,587,850 across 95 Biotechnology names. INCY ranks #23 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
896,397 | $205,032,885 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
426,523 | $190,459,579 | |
| 3 | INSM |
INSMED Inc
|
916,464 | $149,860,192 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
1,330,415 | $98,796,617 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
120,425 | $93,045,171 | |
| 6 | GPCR |
Structure Therapeutics Inc.
|
1,753,764 | $84,531,424 | |
| 7 | CYTK |
Cytokinetics Inc
|
1,093,485 | $72,071,595 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
350,488 | $59,239,481 |
All Filings in INCY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,223,306 | 225,492 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $21,820,465 | 220,922 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $18,261,204 | 215,319 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $14,148,115 | 207,755 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $12,954,490 | 213,947 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $14,679,308 | 212,528 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $14,591,574 | 220,750 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $15,026,970 | 247,888 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $14,433,462 | 253,352 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $15,925,929 | 253,638 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $15,037,126 | 260,293 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $16,235,920 | 260,818 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $19,410,926 | 268,589 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $21,480,458 | 267,436 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $18,023,920 | 270,467 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $18,375,775 | 241,882 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $18,816,821 | 236,928 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $17,184,701 | 234,124 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $16,389,035 | 238,282 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $19,846,771 | 235,906 | Shares | Defined | 2021-08-10 | |
| 2020-12-31 | $22,138,061 | 254,519 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $24,659,115 | 274,784 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $29,604,312 | 284,739 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $19,206,910 | 262,282 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||